Deciphera Pharmaceuticals Inc (DCPH.OQ)
24.23USD
20 Apr 2018
$0.09 (+0.37%)
$24.14
$24.03
$24.40
$23.71
25,906
61,018
$29.97
$15.37
Latest Key Developments (Source: Significant Developments)
Deciphera Pharmaceuticals Q4 Loss Per Share $0.62
March 28 (Reuters) - Deciphera Pharmaceuticals Inc
Deciphera Pharmaceuticals Q3 loss $5.85 per share
Nov 14 (Reuters) - Deciphera Pharmaceuticals Inc
New Leaf Venture reports 12.9 pct stake in Deciphera Pharmaceuticals
Oct 11 (Reuters) - Deciphera Pharmaceuticals Llc
Viking Global Investors reports 8.1 pct passive stake in Deciphera Pharmaceuticals
Oct 11 (Reuters) - Deciphera Pharmaceuticals Llc
Deciphera Pharmaceuticals shares open 17.9 pct above IPO price in debut
Sept 28 (Reuters) - :Deciphera Pharmaceuticals shares open at $20.05 in debut on NASDAQ vs IPO price of $17 per share. Full Article
BRIEF-Deciphera Pharma Initiates Late Stage Study In Gastrointestinal Cancer Patients
* DECIPHERA PHARMACEUTICALS INITIATES PHASE 3 CLINICAL STUDY WITH DCC-2618 IN PATIENTS WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS (“INVICTUS” STUDY)
Earnings vs. 
Estimates